ADVI Health is excited to announce the acquisition of Partnership for Health Analytic Research (PHAR), a leading global consultancy specializing in health technology assessment (HTA) and health economics and outcomes research (HEOR). PHAR is renowned for delivering impactful, data-driven insights to major biopharmaceutical clients. This acquisition enhances ADVI’s Strategic Analytics, Value and Economics (SAVEs) team, significantly expanding its capabilities in HTA/HEOR, primary research, literature review, and patient registry analysis.
“As the healthcare landscape evolves, so do our clients’ needs. With decades of expertise, PHAR significantly enhances our SAVEs and Market Access teams. We’re excited to expand and improve our services for our clients,” said Marc Samuels, CEO of ADVI.
The acquisition aligns with ADVI’s mission to be the premier market partner for life sciences innovators, aiding clients in advancing patient access, accelerating reimbursement, and achieving optimal results. By integrating PHAR’s expertise in data analytics and implementation science, ADVI strengthens its capabilities in clinical and retrospective value assessments.
Marc Samuels and Caitlin Sheetz, Head of SAVEs, extend a warm welcome to Dr. Michael Broder, PHAR’s founder, Eunice Chang, PhD, and the entire PHAR team. “Joining ADVI is an exciting opportunity for us. We look forward to leveraging our data to deliver impactful results for both longstanding and new clients,” said Dr. Broder. “As novel therapeutics emerge, demonstrating their true value through data is crucial for successful brand launches, market access, and life cycle management.”
About ADVI Health
ADVI Health is a strategic consulting partner in the healthcare and life sciences sectors, with offices in Austin, Chicago, San Francisco, and Washington, D.C. We tackle complex healthcare challenges through data-informed commercialization, market access, and policy solutions. Our Strategic Analytics, Value, and Economics (SAVEs) capabilities cover multiple payer segments and over 200 million lives, providing essential insights and competitive intelligence across the product lifecycle.
